12
Feb 25
New Data from the BELIEVE Trial: Luspatercept and Transfusion-Dependent Beta-Thalassemia
In the field of rare hematological diseases, every new scientific finding represents a step forward toward more effective and personalized treatments. Today, we are pleased to share the editorial published in The Lancet Haematology by Dr. Khaled Musallam, which analyzes the long-term data from the BELIEVE trial on the use…
